Introduction study. All patients included in the analysis fulfilled
Pleural effusion occurs commonly in association one of the following criteria: ~ with primary tuberculosis (l), classically in children I' and adults 3-6 months after infection (2). In developed countries tuberculous pleural effusion is more 2, frequent in older age groups suggesting that it may be 3.
due to reactivation disease (3-5); a recent North 4, American study found a median age of 56 years with 5 (19%) of 26 cases definitely classified as being due to We have examined the records of patients notified 6.
with tuberculous pleural effusions in Edinburgh from 2. They had a calcified primary complex on the chest radiograph. 3. They had a documented positive tuberculin test at least 1 year prior. 4. They had cavitating upper lobe or apical segment of lower lobe disease. Those not defined as primary or reactivation disease remained unclassified.
Details of clinical and radiological findings and test results were extracted from the case records. The size of the effusion on the radiograph at first presentation was classified as small, medium or large as previously defined (7). The post-treatment chest radiograph read by two observers blind to previous therapy was classified as showing either no or some residual pleural abnormality.
Results
The age and sex distribution of patients in the primary, reactivation and unclassified tuberculous pleural effusion groups are shown in Fig. 1 .
Fourteen patients (6 M, 8 F) with a mean age of 27.6 years (range 1 l-5 1 years) had primary tuberculous pleural effusion; four had recent tuberculin skin test conversion; five had returned from a high prevalence area; seven had had recent exposure to an infectious case; three had recent normal chest radiographs and one had hilar adenopathy with parenchyma1 disease.
Twenty-five patients (21 M, 4 F) with a mean age of 51 years (range 19-79 years) had reactivation tuberculous pleural effusion; five had had previous chemotherapy for tuberculosis; 12 had radiological evidence of past disease; three had had a positive tuberculin test at least 1 year previously and nine patients had parenchymal disease with cavitating lesions confined to the upper lobes or superior segment of the lower lobe.
Twenty-three patients (19 M, 4 F) with a mean age of 48.9 years (range 25-85 years) did not meet any of the criteria for classification as either primary or reactivation tuberculous pleural effusion.
There were no significant clinical differences between the groups with cough, sputum, pleuritic chest pain, dyspnoea, weight loss and night sweats being the predominant symptoms (Table 1) . Smoking, alcoholism and non-Caucasian ethnicity were the commonest associated features.
Seventy-five per cent of diagnoses had a definite bacteriological and/or pathological basis. Of pleural aspirates, 4/48 were smear positive and 26/48 culture positive for M tuberculosis. Eighty-seven per cent of aspirates were straw-coloured and 13% bloodstained. Eighty-three per cent of 52 effusions showed lymphocytes predominating, 15% were mixed and 2% had polymorph predominance. Pleural biopsies were taken in 42 cases with caseating granulomata seen in 25 and acid-fast bacilli in eight cases.
The radiological findings are shown in Table 2 . There were more right (32) than left (28), with two bilateral effusions. Parenchymal radiographic shadowing was seen in only l/14 primary and 3123 unclassified disease but in 16125 reactivation disease (BO.005 cf. primary and unclassified groups). Twenty-three of 30 (77%) of patients treated with corticosteroids in addition to chemotherapy showed no residual radiographic pleural abnormality compared to 17/30 (57%) not so treated (P<O.O6).
Discussion
The incidence of tuberculous pleural effusions among notified cases in this study is similar to that reported from Alabama, U.S.A. (4). Classification of tuberculous pleural effusions has no therapeutic implications but identification of a primary case may point to an infectious source case (1). Recognition that not all tuberculous pleural effusions are associated with primary disease and that reactivation disease, as in this study, may be more common, emphasizes the need to consider a tuberculous aetiology when pleural effusion occurs in older age groups.
The mean overall age of our patients (44.9 years) was similar to previous studies (3,4) although we had a higher percentage of defined reactivation disease cases than previously found (3). Many of our patients could not be definitely classified as primary or reactivation disease because we lacked historical data concerning skin test and radiological status. The age and sex profile of our unclassified group is almost identical to that of our reactivation disease group of pleural effusions and significantly different from the profile of the primary pleural effusions (Fig. 1) suggesting that the unclassified group may predominantly represent reactivation disease. The relative absence of parenchymal disease does not preclude reactivation; several of our defined reactivation cases of tuberculous pleural effusion did not exhibit et al. Table 2 ). There is no a priori reason why disease reactivation should not occur in the pleural space in the absence of demonstrable active pulmonary disease; active pulmonary disease does not usually accompany active extrapulmonary disease (8). Reactivation disease in the age group of our unclassified cases is favoured by the observation that the majority of middle-age individuals attending a Chest Clinic in Edinburgh have strongly positive tuberculin skin test reactions indicating previous infection (9). It is also possible that some of our defined primary disease cases, in particular the three cases qualifying on the basis of a previously normal chest radiograph and the five overseas travellers, may actually represent reactivation disease. The possibility of post primary disease due to a second infection also exists, but would be difficult to prove.
The unilateral tuberculous pleural effusions reported in this study confirmed previous findings of a right-sided predominance (Table 2) (7). Although most such effusions resolve when treated without residual effects and lung encasement is rare (l), we did find benefit, admittedly equivocal, from corticosteroid therapy in preventing residual pleural abnormality (Table 3) In conclusion, we found that in Edinburgh from 1980-1991 tuberculous pleural effusion due to defined reactivation disease was commoner than that due to defined primary tuberculous disease. Tuberculous plural effusion in Edinburgh is therefore commoner in middle age than in younger age groups. We also suggest that most of the unclassified cases of tuberculous pleural effusion in our study are more likely to represent reactivation disease than primary disease making reactivation disease over three times more common than primary disease.
